Ovarian Cancer and Us - best viewed in FIREFOX

Google Search: this blog, links from posts and the web.....

Loading...

Monday, February 08, 2010

Is 2010 the beginning of a new medical era? - news article - conference CAM



quick check - PARP clinical trials (ovarian,BRCA,solid tumours)



Med students say conventional medicine would benefit by integrating alternative therapies



Northwest Biotherapeutics Inc. - press release



"The Company is also conducting a Phase I/II trial with DCVax(R) for recurrent metastatic ovarian cancer."

Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval PRNewswire



Marshall Edwards, Inc. Announces Resignation of Christopher Naughton From Board of Directors



Note: the OVATURE ovarian cancer trial results are to be published later this year - Phenoxodiol

abstract: Relationship between dietary and supplemental intake of folate, methionine, vitamin B6 and folate receptor α expression in ovarian tumors




abstract: Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?




Family History, Mammographic Density, and Risk of Breast Cancer — Cancer Epidemiology, Biomarkers & Prevention




Nonsteroidal Anti-Inflammatory Drugs and Risk for Ovarian and Endometrial Cancers in the Iowa Women's Health Study — Cancer Epidemiology, Biomarkers & Prevention




Do Canadian patients trust others like them?



"Trust in a “person like yourself” has decreased from 2008 to 2009 (as have most information sources listed in the report), and dropped again in 2010. From the global 2010 Edelman report, 44% of respondents aged between 25-64 years said they would find the information from a person like them to be either ‘very credible’ or ‘extremely credible’ (down from 47% in 2009, and 58% in 2008). That’s a huge drop over the past 3 years!......Another point to keep in mind is that a “person like yourself” is not the same as a “patient like yourself”. "

Estrogen-only HRT may increase risk of asthma after menopause | Eureka! Science News




Enhancing adoptive immunotherapy of cancer; Expert Opinion on Biological Therapy